OprD mutations and inactivation, expression of efflux pumps and AmpC, and metallo-β-lactamases in carbapenem-resistant Pseudomonas aeruginosa isolates from South Korea

International Journal of Antimicrobial Agents

Volumn 40, Issue 2, 2012, Pages 168-172

  Lee, Ji Young ^a   Ko, Kwan Soo ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Carbapenems; IMP 6; OprD

Indexed keywords

AMIKACIN; BETA LACTAMASE AMPC; CARBAPENEM; CARRIER PROTEIN; CEFEPIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; COLISTIN; IMIPENEM; MEROPENEM; METALLO BETA LACTAMASE; OUTER MEMBRANE PROTEIN; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN B; PORIN; PROTEIN MEXAB; PROTEIN OPRD; SULPERAZON; SULTAMICILLIN; TETRACYCLINE; UNCLASSIFIED DRUG;

AMPC GENE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; CARBAPENEM RESISTANT PSEUDOMONAS AERUGINOSA; GENE EXPRESSION; GENE INACTIVATION; GENE MUTATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; OPRD GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; SOUTH KOREA;

ANTI-BACTERIAL AGENTS; BACTEREMIA; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL PROTEINS; BETA-LACTAMASES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENE EXPRESSION REGULATION, BACTERIAL; GENE SILENCING; GENES, BACTERIAL; HUMANS; IMIPENEM; MICROBIAL SENSITIVITY TESTS; MUTATION; PORINS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; REPUBLIC OF KOREA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THIENAMYCINS; URINARY TRACT INFECTIONS;

EID: 84864290041     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2012.04.004     Document Type: Article

References (15)

1. K. Poole Pseudomonas aeruginosa: resistance to the max Front Microbiol 2 2011 65
2. T.A. Davies, A. Marie Queenan, B.J. Morrow, W. Shang, K. Amsler, and W. He Longitudinal survey of carbapenem resistance and resistance mechanisms in Enterobacteriaceae and non-fermenters from the USA in 2007-09 J Antimicrob Chemother 66 2011 2298 2307
3. J.M. Rodríguez-Martínez, L. Poirel, and P. Nordmann Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa Antimicrob Agents Chemother 53 2009 4783 4788
4. G. Cornaglia, H. Giamarellou, and G.M. Rossolini Metallo-β- lactamases: a last frontier for β-lactams? Lancet Infect Dis 11 2011 381 393
5. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: twenty-first informational supplement. Document M100-S21. Wayne, PA: CLSI; 2011.
6. A.P. Magiorakos, A. Srinivasan, R.B. Carey, Y. Carmeli, M.E. Falagas, and C.G. Giske Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance Clin Microbiol Infect 18 2012 268 281
7. J. Quale, S. Bratu, D. Landman, and R. Heddurshetti Molecular epidemiology and mechanisms of carbapenem resistance in Acinetobacter baumannii endemic in New York City Clin Infect Dis 37 2003 214 220
8. J.L. Dumas, C. van Delden, K. Perron, and T. Köhler Analysis of antibiotic resistance gene expression in Pseudomonas aeruginosa by quantitative real-time-PCR FEMS Microbiol Lett 254 2006 217 225
9. G. Cabot, A.A. Ocampo-Sosa, F. Tubau, M.D. Macia, C. Rodríguez, and B. Moya Overexpression of AmpC and efflux pumps in Pseudomonas aeruginosa isolates from bloodstream infections: prevalence and impact on resistance in a Spanish multicenter study Antimicrob Agents Chemother 55 2011 1906 1911
10. J. Wang, J.Y. Zhou, T.T. Qu, P. Shen, Z.Q. Wei, and Y.S. Yu Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Chinese hospitals Int J Antimicrob Agents 35 2010 486 491
11. E. Riera, G. Cabot, X. Mulet, M. García-Castillo, R. del Campo, and C. Juan Pseudomonas aeruginosa carbapenem resistance mechanisms in Spain: impact on the activity of imipenem, meropenem, and doripenem J Antimicrob Chemother 66 2011 2022 2027
12. O. Gutiérrez, C. Juan, E. Cercenado, F. Navarro, E. Bouza, and P. Coll Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals Antimicrob Agents Chemother 51 2007 4329 4335
13. J. Quale, S. Bratu, J. Gupta, and D. Landman Interplay of efflux system, ampC, and oprD expression in carbapenem resistance of Pseudomonas aeruginosa clinical isolates Antimicrob Agents Chemother 50 2006 1633 1641
14. R.A. Bonomo, and D. Szabo Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa Clin Infect Dis 43 Suppl. 2 2006 S49 S56
15. S. Fraud, and K. Poole Oxidative stress induction of the MexXY multidrug efflux genes and promotion of aminoglycoside resistance development in Pseudomonas aeruginosa Antimicrob Agents Chemother 55 2011 1068 1074